iCAD, Inc. (iCAD) is a provider of image analysis and workflow solutions that enable radiologists and other healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a range of high-performance, expandable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT)). iCAD's solutions aid in the early detection of the prevalent cancers including breast, prostate and colon cancer. The Company's CAD systems include algorithm and other technology together with standard computer and display equipment. CAD systems for the film-based analog mammography market also include a radiographic film digitizer, either manufactured by the Company or others for the digitization of film-based medical images. !

iCAD, Inc. (iCAD) is a provider of image analysis and workflow solutions that enable radiologists and other healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a range of high-performance, expandable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT)). iCAD's solutions aid in the early detection of the prevalent cancers including breast, prostate and colon cancer. The Company's CAD systems include algorithm and other technology together with standard computer and display equipment. CAD systems for the film-based analog mammography market also include a radiographic film digitizer, either manufactured by the Company or others for the digitization of film-based medical images. !

Speke is ScribeAmerica's Ambient AI Scribe solution. We pair the latest AI technology with our scribes to create an enterprise solution, utilized in 80 specialties on the ambulatory side, acute setting, and urgent care. It is customized down to the individual provider. Speke is highly scalable, EMR agnostic, and cost effective.

ScribeAmerica was established in 2003, while the concept of medical scribe utilization in the industry has been anecdotally reported since the 1970's, ScribeAmerica transformed this cottage operation into a national industry. In 2006, we were the first company to demonstrate that the synergy of the Scribe/MD/EMR model could overcome productivity losses experienced by unassisted physicians using EMR. In 2008, we were the first scribe company providing services on both coasts and the only scribe company present at ACEP, AAOS, and SHM. We credit our success to our generous profit-sharing business model whereby the actual Project Leaders who manage our client's programs are rewarded. By enfranchising our employee base, we ensure limited attrition among management and attract the best talent in the industry to run your program.

Speke is agnostic the the EHR. While recommended, we can support Speke without EHR integrations which promotes fast and small pilots to prove provider buy-in and overall adoption.